title: Same-day initiation of the transdermal hormonal delivery system (contraceptive patch) versus traditional initiation methods.
abstract: BACKGROUND
  Published comparisons of oral contraceptive pill (OCP) initiation methods demonstrate that OCP initiation at the office visit ("Quick Start") resulted in higher continuation rates into the second cycle. This trial was performed to investigate whether Quick Start with the contraceptive patch would provide similar results.
  
  
  METHODS
  Sixty women were randomized to initiate use of the contraceptive patch using Quick Start (Group 1, n=30) or on the first day of their next menses (Group 2, n=30). Telephone contact at 6 weeks occurred to ensure that the second cycle had been initiated. A single follow-up visit was scheduled after completion of the third patch cycle.
  
  
  RESULTS
  Continuation rates for Groups 1 and 2 were 97% and 93% (p=1.0), respectively, into the second cycle, and 93% and 90%, respectively, into the third cycle (p=1.0). Only approximately half of the subjects planned to continue using the patch after the study.
  
  
  CONCLUSIONS
  Quick Start for the contraceptive patch did not improve continuation rates into the second or third cycle.
authors.affiliation: Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine/Magee Womens Research Institute, Pittsburgh, PA 15213, USA.
authors.forename: Amitasrigowri S
authors.initials: AS
authors.lastname: Murthy
authors.forename: Mitchell D
authors.initials: MD
authors.lastname: Creinin
authors.forename: Bryna
authors.initials: B
authors.lastname: Harwood
authors.forename: Courtney A
authors.initials: CA
authors.lastname: Schreiber
mesh_terms: D000279:Administration, Cutaneous; D000293:Adolescent; D000328:Adult; D003270:Contraceptive Agents / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D010349:Patient Compliance; D010865:Pilot Projects; D011446:Prospective Studies
chemical_list: D003270:Contraceptive Agents